PAX5 and acute lymphoblastic leukemia: The PAX5‐JAK2+ B‐ALLs belong to the Philadelphia chromosome‐like (Ph‐like) ALL subgroup, which is characterized by genetic alterations leading to constitutive activation of kinase signaling (Roberts et al, 2012, 2014).